MID-C 105
Report
- Report Number
- 3013461531-2021-00037
- Event Type
- Injury
- Date Received
- October 25, 2021
- Date of Event
- October 4, 2021
- Report Date
- October 23, 2021
- Manufacturer
- APIFIX LTD
- Product Code
- QGP
- PMA / PMN Number
- H170001
- Adverse Event
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- GM
- Reporter Occupation
- OTHER
Narratives
FIRST INVESTIGATION: PRODUCTION PROCESS ANALYSIS: A REVIEW OF THE DHR DEMONSTRATED THAT THE MID-C SYSTEM WAS MANUFACTURED, TESTED, AND RELEASED ACCORDING TO SPECIFICATION. USER (SURGEON AND PATIENT) INFORMATION ANALYSIS: THE TISSUE WAS SENT FOR LABORATORY ANALYSIS, A FULL INVESTIGATION WILL BE DONE ONCE THE IMPLANT ARRIVES AT APIFIX.. DESIGN: THE MID-C IMPLANT IS COATED WITH ADLC COATING ON ALL MOVING PARTS WHICH REDUCES THE AMOUNT OF WEAR DEBRIS. THE COATING DESIGN WAS VALIDATED AND APPROVED FOR ITS USE. EVALUATION OF LOCAL AND SYSTEMATIC EFFECTS OF WEAR DEBRIS DMS- 2909. DMS-761 MID-C V&V REPORT . DMS 4449 IN SILICO ANALYSIS AND TOXICOLOGICAL RISK ASSESSMENT OF EXTRACTABLE COMPOUNDS. FROM THE APIFIX MID-C SYSTEM DEVICE USED FOR THE TREATMENT OF ADOLESCENT IDIOPATHIC SCOLIOSIS (AIS). DMS 4243 - ISO 10993-18 - CHEMICAL CHARACTERIZATION. ALSO, THE COATING PROCESS WAS VALIDATED PER OQ DMS-5522 AND PQ DMS-5588. RISK ASSESSMENT: THE RISK OF "WEAR DEBRIS FROM MOVING PARTS, DEGRADATION, LEACHABLE ON THE IMPLANT AND THE BODY" HAS BEEN ASSES ACCORDING TO RISK FILE DMS-777 REV Q HAZARD ID 21.6 AND FOUND TO BE ACCEPTABLE.
THE SURGEON DECIDED TO PERFORM ELECTIVE SURGERY TO REPLACE THE EXISTING MID-C ROD IMPLANT WITH A LONGER SIZE IMPLANT SINCE THE PATIENT HAS GROWN AND THE IMPLANT REACHED ITS MAXIMAL ELONGATION. DURING THE REOPERATION, THE SURGEON DETECTED A BLACK DISCOLORATION OF THE TISSUE IN AREA OF THE IMPLANT.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 1591705 | MID-C 105 | POSTERIOR RATCHETING ROD SYSTEM,,, | QGP | APIFIX LTD | MID-C 105 | AF 11-01-17 |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | Required Intervention |